MarketGrader India Small Cap 100 Index


Five Largest Companies
Symbol Name Grade Market Cap Country
532144.IN Welspun Corp Limited 50.4 ¤4,437 IN
544210.IN Emcure Pharmaceuticals Limited 56.4 ¤3,594 IN
500184.IN Himadri Speciality Chemical Ltd. 62.0 ¤3,487 IN
504973.IN Cholamandalam Financial Holdings Ltd 58.7 ¤3,250 IN
590003.IN Karur Vysya Bank Ltd. 67.5 ¤3,093 IN

Five Smallest Companies
Symbol Name Grade Market Cap Country
538920.IN Vintage Coffee and Beverages Limited 64.5 ¤246 IN
524394.IN Vimta Labs Limited 64.8 ¤265 IN
535754.IN Orient Cement Ltd. 53.6 ¤297 IN
544232.IN Interarch Building Solutions Ltd 44.9 ¤323 IN
532150.IN Indraprastha Medical Corporation Limited 55.8 ¤365 IN

Companies with Most Selections Among Current Components
Symbol Name Grade Times* Country
532772.IN DCB Bank Limited 55.4 23 IN
520113.IN Vesuvius India Ltd 48.6 21 IN
532482.IN Granules India Limited 57.2 19 IN
524816.IN NATCO Pharma Limited 47.1 18 IN
533023.IN ZF Commercial Vehicle Control Systems In 54.9 18 IN
532210.IN City Union Bank Limited 56.7 17 IN
532531.IN Strides Pharma Science Ltd 56.8 17 IN
590003.IN Karur Vysya Bank Ltd. 67.5 17 IN
524404.IN Marksans Pharma Limited 62.3 16 IN
532218.IN South Indian Bank Limited 61.0 16 IN
*Number of times selected at Index semi-annual reconstitutions since inception date.
Index Bio
Average Market Cap ¤1,401
Median Market Cap ¤1,238
Avg. 3 Mo. Dollar Vol. ¤580,825
Avg. 3 Mo. Trading Vol. 97,894
Last Rebalance Date 03/23/2026
Companies Replaced 39
Biggest Sector Increase Technology
Biggest Sector Decrease Materials

Fundamental Attributes
Trailing P/E Ratio (12 Mo.) 23.4
Forward P/E Ratio (12 Mo.) 17.8
Price/Book Ratio 3.4
Avg. Revenue Chg. - 3 Yr 53.8%
Avg. Op. Income Chg. - 3 Yr. 113.1%
Avg. EPS Growth - 3 Yr. 25.9%
Avg. EPS Growth - 1 Yr. 27.4%
Avg. Operating Margin 14.9%
Avg. LT Debt to Total Capital 16.1%
Avg. Return on Equity 17.4%
Dividend Yield 0.4%
Index Average Grade
India Small Cap 100 Index 56.37
Country Breakdown
India 100.0%
For more information on this index please contact us

Get Access to the World's Smartest Global Research Platform

Don't wait another day to make better informed, higher-returning investments.

TRY IT FOR FREE